Indication
Acute Heart Failure With Reduced Ejection Fraction
1 clinical trial
2 products
Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of APD418 in Subjects With Heart Failure With Reduced Ejection FractionStatus: Terminated, Estimated PCD: 2022-09-19
Product
APD418Product
Placebo